Apolipoprotein E genotype in senile dementia with tangles differs from Alzheimer's disease [2]

Neuropathology and Applied Neurobiology

Volumn 29, Issue 1, 2003, Pages 80-84

  Tolnay, M ^a   Villoz, N ^a   Probst, A ^a   Miserez, A R ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; MONOCLONAL ANTIBODY;

AGED; ALLELE; ALZHEIMER DISEASE; ARGYROPHILIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; SENILE DEMENTIA; SENILE PLAQUE; TAUOPATHY;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; BRAIN; DEMENTIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLES; NEUROPIL THREADS; POLYMERASE CHAIN REACTION; SENILE PLAQUES; TAU PROTEINS;

EID: 0037329273     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2003.04032.x     Document Type: Letter

References (24)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994
2. Bancher C, Jellinger KA. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathol 1994; 88: 565-70
3. Bancher C, Egensperger R, Kösel S, Jellinger K, Gräber MB. Low prevalence of apolipoprotein E E4 in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol 1997; 94: 403-9
4. Braak H, Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989; 15: 13-26
5. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59
6. Braak E, Braak H, Mandelkow E. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994; 87: 554-67
7. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993; 261: 921-3
8. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morph Acad Sci Hung 1971; 19: 1-8
9. Ghebremedhin E, Schultz C, Botez G et al. Argyrophilic grain disease is associated with apolipoprotein E ε2 allele. Acta Neuropathol 1998; 96: 222-4
10. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995; 189: 167-70
11. Ikeda K, Akiyama H, Sahara N et al. A subset of senile dementia with high incidence of the apo E ε2 allele. Ann Neurol 1997; 41: 693-5
12. Jellinger K, Bancher C. Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol 1998; 8: 367-76
13. Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000; 31: 1299-306
14. Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessement of Alzheimer's disease. Neurology 1991; 41: 479-86
15. Miserez AR, Laager R, Chiodetti N, Keller U. High prevalence of familial defective apolipoprotein B-100 in Switzerland. J Lipid Res 1994; 35: 574-83
16. Miserez AR, Keller U. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995; 15: 1719-29
17. Miserez AR. Genetik und Molekularbiologie. In Memorix Innere Medizin. Ed, von Planta M. London: Chapman & Hall, 1996: 25-44
18. Nakayama S, Kuzuhara S. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie prefecture of Japan. Psychiatry Clin Neurosci 1999; 53: 643-8
19. Polvikoski T, Sulkava R, Haltia M et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995; 333: 1242-7
20. Tolnay M, Probst A, Monsch AU, Staehelin HB, Egensperger R. Apolipoprotein E allele frequencies in argyrophilic grain disease. Acta Neuropathol 1998; 96: 225-7
21. Tolnay M, Calhoun M, Pham HC, Egensperger R, Probst A. Low amyloid (Aβ) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease. Neuropathol Appl Neurobiol 1999; 25: 295-305
22. Tolnay M, Monsch AU, Probst A. Argyrophilic grain disease. A frequent disorder in aged patients. In Advances in Experimental Medicine and Biology, Vol. 487: Neuropathology and Genetics of Dementia. Eds. Tolnay M, Probst A. New York: Kluwer Academic/Plenum Publishers. 2001: 39-58
23. Ulrich J, Spillantini MG, Goedert M, Dukas L, Stähelin HB. Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegeneration 1992; 1: 257-84
24. Yamada M, Itho Y, Sodeyama N et al. Senile dementia of the neurofibrillary tangle type: a comparison with Alzheimer's disease. Dement Geriatr Cogn Disord 2001; 12: 117-26